Iroquois Capital Management, LLC 13D and 13G filings for MYMD PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:27 am Purchase | 2023-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Iroquois Capital Management, LLC | 1,689 4.990% | 1,099 (+186.27%) | Filing |
| 2023-02-14 07:40 am Sale | 2022-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Iroquois Capital Management, LLC | 590 6.470% | -136 (-18.73%) | Filing |
| 2022-02-23 4:45 pm Sale | 2021-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Iroquois Capital Management, LLC | 726 9.560% | -315 (-30.26%) | Filing |